Invention Grant
- Patent Title: Toxicity assay based on human blastocyst-derived stem cells and progenitor cells
- Patent Title (中): 基于人胚泡干细胞和祖细胞的毒性测定
-
Application No.: US12444017Application Date: 2007-10-02
-
Publication No.: US08153359B2Publication Date: 2012-04-10
- Inventor: Raimund Strehl , Sarah Adler
- Applicant: Raimund Strehl , Sarah Adler
- Applicant Address: SE Gothenburg
- Assignee: Cellartis AB
- Current Assignee: Cellartis AB
- Current Assignee Address: SE Gothenburg
- Agency: Buchanan Ingersoll & Rooney PC
- International Application: PCT/EP2007/008576 WO 20071002
- International Announcement: WO2008/040532 WO 20080410
- Main IPC: C12Q1/00
- IPC: C12Q1/00 ; G01N33/53 ; C12N5/00 ; C12N5/02 ; C12N5/08

Abstract:
An in vitro toxicity assay based on human blastocyst-derived stem cells for the detection of toxicity in the human species is provided, which enables novel detection of in vitro human toxicity for a substance and/or more efficiently detects human toxicity compared to non-human assays. Furthermore, the detection of toxicity for substances is enabled, which is known to display inter-species differences and the toxic effect was not detectable by toxicological tests in mice.
Public/Granted literature
- US20100047842A1 NOVEL TOXICITY ASSAY BASED ON HUMAN BLASTOCYST-DERIVED STEM CELLS AND PROGENITOR CELLS Public/Granted day:2010-02-25
Information query